Recombinant expression systems in the pharmaceutical industry

Area of Science:

• Biotechnology
• Protein Engineering
• Molecular Biology

Background:

• Secretory expression systems offer advantages in downstream processing for recombinant protein production compared to cytosolic systems.
• Current secretory systems struggle to achieve competitive yields for high-volume therapeutics like insulin.
• Optimization strategies are crucial for enhancing protein production and secretion efficiency.

Purpose of the Study:

• To review and discuss strategies for improving the efficiency of secretory expression systems for recombinant protein production.
• To evaluate the suitability of different host organisms, including prokaryotes, fungi, insect, and mammalian cells, for specific protein production needs.
• To highlight the importance of understanding posttranslational modifications for optimizing protein folding and secretion.

Main Methods:

• Review of current strategies for enhancing gene expression, optimizing signal sequences, and utilizing chaperones and foldases.
• Analysis of protease-deficient mutants to prevent premature protein degradation.
• Discussion of host system selection, including Escherichia coli, Bacillus species, fungal, insect, and mammalian cells.
• Exploration of genetic engineering and mutagenesis approaches for strain improvement.

Main Results:

• Prokaryotes, such as Escherichia coli and Bacillus species, are suitable for non-glycosylated proteins due to their lack of glycosylation pathways.
• Fungal species require deeper understanding of glycosylation for optimizing folding and secretion.
• Insect and mammalian cells are suitable for proteins requiring human-like posttranslational modifications, despite higher costs.

Conclusions:

• Improving secretory expression systems is vital for competitive recombinant protein production, especially for therapeutics.
• Host system selection and optimization of posttranslational modifications are key factors for successful protein production.
• Further research into glycosylation pathways and host engineering is needed to fully exploit secretory capacities.